|
|
|
|
|
by klmr
2046 days ago
|
|
> When in fact there is no data at the moment to support their safeness. That’s patently untrue. We have data, from the phase III trials. Is the data final? No. But it’s good evidence for general safety. As for long-term problems, we have good theoretical reasons (based, in turn, on experimental data) to suspect that no such risks exist. In fact, we know quite a lot about how foreign RNA behaves in cells and while there are potential mechanisms to cause issues (most importantly strong immune reactions), there are no known plausible mechanisms to cause long-term problems. We can’t fully exclude the possibility of long-term averse effects, but we do have data supporting the vaccines’ safety (both direct and indirect, experimental data), and most experts are confident that there won’t be any such effects — confident enough to put their own health on the line: many are enrolled in the ongoing trials. |
|